REG - Directa Plus PLC - Total Voting Rights
RNS Number : 2155UDirecta Plus PLC27 July 202027 July 2020
Directa Plus plc
("Directa Plus" or the "Company")
Total Voting Rights
Directa Plus (AIM: DCTA) announces that the Company's issued share capital comprises 61,174,587 Ordinary Shares and the total number of voting rights in the Company is 61,174,587. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.
Further to the exercise of share options announced in early July, the Company realised that it was necessary to apply for the admission to trading on AIM of 1 additional new ordinary share ("Admission"). This additional share is included in the issued capital detailed above. Such application has been made to the London Stock Exchange and it is expected that Admission will become effective at 8.00 a.m. on 31 July 2020.
For further information please visit http://www.directa-plus.com/ or contact:
Directa Plus plc
+39 02 36714458
Giulio Cesareo, CEO
Marco Ferrari, CFO
Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)
+44 20 7894 7000
Rick Thompson, Philip Davies, Will Goode (Corporate Finance)
N+1 Singer (Joint Broker)
+44 20 7496 3069
Mark Taylor
Tavistock (Financial PR and IR)
+44 20 7920 3150
Simon Hudson, Edward Lee
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.
-ends-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDTVREDLFLBDLZBBX
Recent news on Directa Plus
See all newsREG - Directa Plus PLC - Full year trading and operational update
AnnouncementREG - Directa Plus PLC - Grant of 2025 LTIP Awards
AnnouncementREG - Directa Plus PLC - Half Year Report
AnnouncementREG - Directa Plus PLC - Notice of interim results presentations
AnnouncementREG - Directa Plus PLC - PDMR Dealing
Announcement